Yesterday Regen BioPharma Inc (OTCMKTS:RGBP) was one of the companies that came into the news cycle after it announced that two new members had joined its Scientific Advisory Board. The company announced yesterday that Dr Mohammad Haris, Associate Professor at the University of Pennsylvania and Dr Ravinder Reddy, Professor of Radiology at the University of Pennsylvania had joined the scientific advisory board.
Trading Data
On Wednesday, RGBP stock moved down 4.17% to $0.0046 with more than 11.94 million shares, compared to its average volume of 15.13 million shares. The stock moved within a range of $0.0043 – 0.0050 after opening trade at $0.0044.
Regen BioPharma Appoints Two New Scientific Advisory Board Members
It was a significant new announcement from the company and one that could be of interest to investors as well. In this situation, it may be a good move for investors to perhaps take a look at some of the credentials of the personnel before making their minds up about the Regen stock one way or another.
It should be noted that Dr Reddy is also the Director of the Center for Advanced Metabolic Imaging in Precision Medicine at the university. He is involved in research related to structural and molecular changes in a range of diseases and that also includes cancer.
On the other hand, Dr Haris is a professor at the Center for Advanced Metabolic Imaging in Precision Medicine at the University. He boasts of considerable experience in examining the different dynamics of cancer.
Key Quote
“As we grow our CAR T-cell and other immunotherapy programs, we need the expertise of senior scientists associated with the top academic medical centers in the U.S. In fact, CAR T-cell therapy was first developed at the University of Pennsylvania and, with their big pharma partner Novartis, they got the first CAR T-cell therapy approval in 20171,” said Dr. David Koos, CEO and Chairman. “We are absolutely delighted to have Drs. Reddy and Haris join us.”
Technical Data
RGBP stock is trading below the 20-Day and 50-Day Moving averages of $0.0050 and $0.0055 respectively. Moreover, the stock is trading below the 200-Day moving average of $0.0063.
